Product Reports Resources Pricing Login Book a demo

WuXi AppTec

Biotech & Life Sciences · Huangpu, China · Founded 2000 · IPO 2018

A global pharmaceutical, biopharmaceutical, and medical device outsourcing company

Valuation $49B
Revenue $7.38B
EBITDA $3.37B

Talent graph

WuXi AppTec's talent

Book a demo to see the people
Employees mapped 4,283 incl. 2 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 9 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 7 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

1 investor on WuXi AppTec's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Global footprint

Where WuXi AppTec has talent and traffic

Workforce by country
25 countries with
team presence
🇨🇳 China62%
🇺🇸 United States29.7%
🇨🇭 Switzerland1.9%
🇬🇧 United Kingdom1.1%
🇩🇪 Germany1%
Top 5 of 25 shown
Web traffic by country
180K monthly visits
across markets
🇨🇳 China48.6%
🇺🇸 United States14.3%
🇬🇧 United Kingdom9.8%
🇩🇪 Germany2.2%
🇦🇺 Australia1.8%
Top 5 markets shown

Patent intelligence

$315M patent portfolio · 1,444 active families

Estimated portfolio value
$315M
0.65% of market cap · 4.2× larger than top peer Haisco ($74M)
1,444 active patent families
Where WuXi AppTec innovates Combinatorial chemistryMechanical engineeringAcetic acidCarboxylic acidDisease

Where WuXi AppTec concentrates vs peers

Each axis is a top-10 topic across WuXi AppTec and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

WuXi AppTec's 42 investments and acquisitions.

Every disclosed deal where WuXi AppTec appeared as a backer or acquirer, 2014–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

42 deals across WuXi AppTec's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where WuXi AppTec deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        WuXi AppTec's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        42 of 42 deals

        Market sentiment

        What the market is saying about WuXi AppTec

        An AI-synthesized read of the highest-engagement posts about WuXi AppTec on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See WuXi AppTec on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.